The North-South Divide

Substance Use Risk, Care Engagement, and Viral Suppression Among Hospitalized Human Immunodeficiency Virus-Infected Patients in 11 US Cities

Morgan M. Philbin, Daniel J. Feaster, Lauren Gooden, Rui Duan, Moupali Das, Petra Jacobs, Gregory M. Lucas, D. Scott Batey, Ank E Nijhawan, Jeffrey M. Jacobson, Raul Mandler, Eric Daar, Deborah K. McMahon, Wendy S. Armstrong, Carlos Del Rio, Lisa R. Metsch

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Regional variability in human immunodeficiency virus (HIV) care engagement remains underexplored. Multiple logistic models compared HIV outcomes for participants from 5 Southern (n = 557) and 6 non-Southern (n = 670) sites. Southern participants were less likely to experience viral suppression (adjusted odds ratio [aOR], 0.52; 95% confidence interval [CI], .37-.72) and had a higher likelihood of a CD4+ count <200 cells/µL (aOR, 1.53; 95% CI, 1.17-2.00). HIV intervention and social safety net programs should be expanded. Clinical Trials Registration: NCT01612169.

Original languageEnglish (US)
Pages (from-to)146-149
Number of pages4
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume68
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

HIV
Odds Ratio
Confidence Intervals
CD4 Lymphocyte Count
Logistic Models
Clinical Trials
Safety

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

The North-South Divide : Substance Use Risk, Care Engagement, and Viral Suppression Among Hospitalized Human Immunodeficiency Virus-Infected Patients in 11 US Cities. / Philbin, Morgan M.; Feaster, Daniel J.; Gooden, Lauren; Duan, Rui; Das, Moupali; Jacobs, Petra; Lucas, Gregory M.; Batey, D. Scott; Nijhawan, Ank E; Jacobson, Jeffrey M.; Mandler, Raul; Daar, Eric; McMahon, Deborah K.; Armstrong, Wendy S.; Del Rio, Carlos; Metsch, Lisa R.

In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 68, No. 1, 01.01.2019, p. 146-149.

Research output: Contribution to journalArticle

Philbin, MM, Feaster, DJ, Gooden, L, Duan, R, Das, M, Jacobs, P, Lucas, GM, Batey, DS, Nijhawan, AE, Jacobson, JM, Mandler, R, Daar, E, McMahon, DK, Armstrong, WS, Del Rio, C & Metsch, LR 2019, 'The North-South Divide: Substance Use Risk, Care Engagement, and Viral Suppression Among Hospitalized Human Immunodeficiency Virus-Infected Patients in 11 US Cities', Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 68, no. 1, pp. 146-149. https://doi.org/10.1093/cid/ciy506
Philbin, Morgan M. ; Feaster, Daniel J. ; Gooden, Lauren ; Duan, Rui ; Das, Moupali ; Jacobs, Petra ; Lucas, Gregory M. ; Batey, D. Scott ; Nijhawan, Ank E ; Jacobson, Jeffrey M. ; Mandler, Raul ; Daar, Eric ; McMahon, Deborah K. ; Armstrong, Wendy S. ; Del Rio, Carlos ; Metsch, Lisa R. / The North-South Divide : Substance Use Risk, Care Engagement, and Viral Suppression Among Hospitalized Human Immunodeficiency Virus-Infected Patients in 11 US Cities. In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2019 ; Vol. 68, No. 1. pp. 146-149.
@article{6ba74305509640bf8ffb29b024c159df,
title = "The North-South Divide: Substance Use Risk, Care Engagement, and Viral Suppression Among Hospitalized Human Immunodeficiency Virus-Infected Patients in 11 US Cities",
abstract = "Regional variability in human immunodeficiency virus (HIV) care engagement remains underexplored. Multiple logistic models compared HIV outcomes for participants from 5 Southern (n = 557) and 6 non-Southern (n = 670) sites. Southern participants were less likely to experience viral suppression (adjusted odds ratio [aOR], 0.52; 95{\%} confidence interval [CI], .37-.72) and had a higher likelihood of a CD4+ count <200 cells/µL (aOR, 1.53; 95{\%} CI, 1.17-2.00). HIV intervention and social safety net programs should be expanded. Clinical Trials Registration: NCT01612169.",
author = "Philbin, {Morgan M.} and Feaster, {Daniel J.} and Lauren Gooden and Rui Duan and Moupali Das and Petra Jacobs and Lucas, {Gregory M.} and Batey, {D. Scott} and Nijhawan, {Ank E} and Jacobson, {Jeffrey M.} and Raul Mandler and Eric Daar and McMahon, {Deborah K.} and Armstrong, {Wendy S.} and {Del Rio}, Carlos and Metsch, {Lisa R.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1093/cid/ciy506",
language = "English (US)",
volume = "68",
pages = "146--149",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - The North-South Divide

T2 - Substance Use Risk, Care Engagement, and Viral Suppression Among Hospitalized Human Immunodeficiency Virus-Infected Patients in 11 US Cities

AU - Philbin, Morgan M.

AU - Feaster, Daniel J.

AU - Gooden, Lauren

AU - Duan, Rui

AU - Das, Moupali

AU - Jacobs, Petra

AU - Lucas, Gregory M.

AU - Batey, D. Scott

AU - Nijhawan, Ank E

AU - Jacobson, Jeffrey M.

AU - Mandler, Raul

AU - Daar, Eric

AU - McMahon, Deborah K.

AU - Armstrong, Wendy S.

AU - Del Rio, Carlos

AU - Metsch, Lisa R.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Regional variability in human immunodeficiency virus (HIV) care engagement remains underexplored. Multiple logistic models compared HIV outcomes for participants from 5 Southern (n = 557) and 6 non-Southern (n = 670) sites. Southern participants were less likely to experience viral suppression (adjusted odds ratio [aOR], 0.52; 95% confidence interval [CI], .37-.72) and had a higher likelihood of a CD4+ count <200 cells/µL (aOR, 1.53; 95% CI, 1.17-2.00). HIV intervention and social safety net programs should be expanded. Clinical Trials Registration: NCT01612169.

AB - Regional variability in human immunodeficiency virus (HIV) care engagement remains underexplored. Multiple logistic models compared HIV outcomes for participants from 5 Southern (n = 557) and 6 non-Southern (n = 670) sites. Southern participants were less likely to experience viral suppression (adjusted odds ratio [aOR], 0.52; 95% confidence interval [CI], .37-.72) and had a higher likelihood of a CD4+ count <200 cells/µL (aOR, 1.53; 95% CI, 1.17-2.00). HIV intervention and social safety net programs should be expanded. Clinical Trials Registration: NCT01612169.

UR - http://www.scopus.com/inward/record.url?scp=85058892160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058892160&partnerID=8YFLogxK

U2 - 10.1093/cid/ciy506

DO - 10.1093/cid/ciy506

M3 - Article

VL - 68

SP - 146

EP - 149

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 1

ER -